Ganaxolone Fragile X Clinical Trial Showed Disappointing Results

Ganaxolone, an experimental drug from Marinus Pharmaceuticals which targets GABA receptors, did not show promise for Fragile X syndrome in a clinical trial.

Read More »

Mega Green Tea Extract to Treat Fragile X?

FRAXA funded a clinical trial of EGCG (green tea extract) on cognitive function in adults with FXS. The team in Barcelona reported memory, attention, and mental flexibility improvements.

Read More »
Dr. Craig Erickson - Fragile X research

Aripiprazole as a Treatment for Fragile X Syndrome

Years ago FRAXA funded Dr. Craig Erickson to run a trial of aripiprazole (aka Abilify). FRAXA guest writer Hannah Miles recently caught up with Dr. Erickson to learn the results of the trial.

Read More »

Categories

FRAXA Funded Research

Current Research Grants (38)